Restricted accessReview articleFirst published online 2011-10
The Retardation of Myometrial Infiltration,Reduction of Uterine Contractility,and Alleviation of Generalized Hyperalgesia in Mice With Induced Adenomyosis by Levo-Tetrahydropalmatine ( l -THP) and Andrographolide
Adenomyosis is a tough disease to manage nonsurgically. Levo-tetrahydropalmatine (l-THP), a known analgesic, and andrographolide, a nuclear factor kappa B (NF-κB) inhibitor, are both active ingredients extracted from Chinese medicinal herbs. We sought to determine whether treatment of l-THP, andrographolide, and valproic acid (VPA) would suppress the myometrial infiltration, improve pain behavior, and reduce uterine contractility in a mice model of adenomyosis. Adenomyosis was induced in 55 female ICR mice neonatally dosed with tamoxifen, while another 8 (group C) were dosed with solvent only. Starting from 4 weeks after birth, hotplate test was administrated to all mice every 4 weeks. At the 16th week, all mice with induced adenomyosis were randomly divided into 6 groups, each receiving different treatment for 3 weeks: low- or high-dose l-THP, andrographolide, low-dose l-THP and andrographolide jointly, VPA, and untreated. Group C received no treatment. After treatment, the hotplate test was administered and all mice were killed. The depth of myometrial infiltration of ectopic endometrium and uterine contractility were measured and compared across groups. We found that induction of adenomyosis resulted in progressive generalized hyperalgesia, along with elevated amplitude and irregularity of uterine contractions. Treatment with either l-THP, andrographolide, VPA, or l-THP and andrographolide jointly suppressed myometrial infiltration, improved generalized hyperalgesia, and reduced the amplitude and irregularity of uterine contractions. These results suggest that increased uterine contractility, in the form of increased contractile amplitude and irregularity, may contribute to dysmenorrhea in women with adenomyosis. More importantly, l-THP, andrographolide, and VPA all seem to be promising compounds for treating adenomyosis.
BergeronCAmantFFerenczyA. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):511–521.
2.
FarquharCBrosensI. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):603–616.
3.
MatalliotakisIMKourtisAI. Panidis DK: Adenomyosis. Obstet Gynecol Clin North Am. 2003;30(1):63–82, viii.
4.
FarquharCBrosensI. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):603–616.
5.
GreenARStylesJAParrottEL. Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol. 2005;56(4-5):255–263.
6.
ParrottEButterworthMGreenAWhiteINGreavesP. Adenomyosis–a result of disordered stromal differentiation. Am J Pathol. 2001;159(2):623–630.
7.
GuoSW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607.
8.
LiuXGuoSW. A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril. 2008;89(1):246–250.
9.
WuYStrawnEBasirZHalversonGGuoSW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics. 2006;1(2):106–111.
10.
NieJLiuXSGuoSW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci. 2010;17(11):995–1005.
11.
LiuXSYuanLGuoSW. Vaproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. 2010; 17(10):904–912.
12.
PickhardtPJKimDHMeniasCOGopalDVArlukGMHeiseCP. Evaluation of submucosal lesions of the large intestine: part 2. Nonneoplastic causes. Radiographics. 2007;27(6):1693–1703.
13.
LeyendeckerGWildtLMallG. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet. 2009;280(4):529–538.
14.
MehassebMKBellSCPringleJHHabibaMA. Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril. 2010;93(7):2130–2136.
15.
MechsnerSGrumBGerickeCLoddenkemperCDudenhausenJWEbertAD. Possible roles of oxytocin receptor and vasopressin-1alpha receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri. Fertil Steril. 2010;94(7):2541–2546.
16.
NieJLiuXGuoSW. Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol. 2010;202(4):346 e341–348.
17.
HuJYJinGZ. Effect of tetrahydropalmatine analogs on Fos expression induced by formalin-pain. Zhongguo Yao Li Xue Bao. 1999;20(3):193–200.
18.
HanYFHouLHZhouYJWuXK. A survey of TCM treatment for endometriosis. J Tradit Chin Med. 2009;29(1):64–70.
19.
ChuHJinGFriedmanEZhenX. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol. 2008;28(4):491–499.
20.
XuJDWangWYangHXLiZQMaLYHouXL. Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smooth muscle strips in virginal rats (in Chinese). J Clin Rehab Tissue Eng Res. 2007;11(5):4178–4181.
21.
ZhaoGJRenSLWuSGYuLS. Effect of L-THP on contraction of blood vessels induced by 5-hydroxytryptamine (in Chinese). Chin J Pharmacol Toxicol. 1988;4(2):342–348.
22.
XingJFWangMNMaXYLiangWWWangYH. Effects of dl tetrahydropalmation on rabbit platelet aggregation and experimental cerebral thrombosis in rats (in Chinese). Chin Pharmacol Bull. 1997;13(5):258–210.
23.
ZhaoTLiuXSZhenXCGuoSW. Levo-tetrahydropalmatine (l-THP) retards the growth of ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced endometriosis in rats. Reprod Sci. 2011;18(1):28–45.
24.
XiaYFYeBQLiYD. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol. 2004;173(6):4207–4217.
25.
NieJLuYLiuXGuoSW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril. 2009;92(3):886–889.
26.
CouncilNR. Guide for the Care and use of Laboratory Animals. Washington, DC: National Academies Press; 1996.
27.
Reagan-ShawSNihalMAhmadN. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659–661.
28.
BirdCCMcElinTWManalo-EstrellaP. The elusive adenomyosis of the uterus–revisited. Am J Obstet Gynecol. 1972;112(5):583–593.
29.
Le BarsDGozariuMCaddenSW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597–652.
30.
BannonAWMalmbergAB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. 2007;Chapter 8:Unit 8 9.
31.
BygdemanMEliassonR. Effect of progesterone and oestrone on the motility and reactivity of the pregnant human myometrium in vitro. J Reprod Fertil. 1964;7:47–52.
32.
CalixtoJBYunesRA. Antagonism of kinin-induced contraction of isolated rat uterus by the crude hydroalcoholic extract from Mandevilla illustris. Gen Pharmacol. 1991; 22(1):99–101.
33.
Hernandez-MagroPMVillanueva SaenzEAlvarez-Tostado FernandezFLuis Rocha RamirezJValdes OvalleM. Endoanal sonography in the assessment of perianal endometriosis with external anal sphincter involvement. J Clin Ultrasound. 2002;30(4):245–248.
34.
PercivalDBWaldenAT. Wavelet Methods for Time Series Analysis. Cambridge, UK: University of Cambridge Press; 2000:594.
35.
BruceAGaoH-Y. Applied Wavelet Analysis With S-PLUS. New York, NY: Springer-Verlag; 1996.
36.
DaubechiesI. Ten Lectures on Wavelets. CBMS-NSF Regional Conference Series in Applied Mathematics. New York, NY: SIAM; 1992.
37.
KooperbergCBoseSStoneCJ. Polychotomous regression. J Am Statist Assoc. 1997;92(3):117–127.
38.
TeamRDC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
39.
CuiLWuT. [L-Tetrahydropalmatine enhances inhibition of cellular proliferation by Vincristine Sulfate in human leukemia cell lines] (in Chinese). Chin Pharmacol Bull. 1995;11(5):348.
40.
LagadecCMeignanSAdriaenssensE. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 2009;28(18):1960–1970.
RibattiDNicoBPerraMT. Correlation between NGF/TrkA and microvascular density in human pterygium. Int J Exp Pathol. 2009;90(6):615–620.
43.
OkajimaKHaradaN. Promotion of insulin-like growth factor-I production by sensory neuron stimulation; molecular mechanism(s) and therapeutic implications. Curr Med Chem. 2008; 15(29):3095–3112.
44.
XuJDWangWYangHXLiZQMaLYHouXL. [Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smooth muscle strips in virgin rats.] (In Chinese). J Clin Rehab Tis Eng Res. 2007;11(5):4178–4181.
45.
HuangKDaiGZLiXH. Blocking L-calcium current by l-tetrahydropalmatine in single ventricular myocyte of guinea pigs. Zhongguo Yao Li Xue Bao. 1999;20(10):907–911.
46.
LatremoliereAWoolfCJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.
47.
KumarATakadaYBoriekAMAggarwalBB. Nuclear factor-kappaB: its role in health and disease. J Mol Med. 2004;82(7):434–448.
48.
ZhangNOppenheimJJ. Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J Leukoc Biol. 2005;78(6):1210–1214.
49.
KunzGNoeMHerbertzMLeyendeckerG. Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update. 1998;4(5):647–654.
50.
WilsonTLigginsGCWhittakerDJ. Oxytocin stimulates the release of arachidonic acid and prostaglandin F2 alpha from human decidual cells. Prostaglandins. 1988;35(5):771–780.
51.
BurnsPDMendesJOJr.YemmRS. Cellular mechanisms by which oxytocin mediates ovine endometrial prostaglandin F2alpha synthesis: role of G(i) proteins and mitogen-activated protein kinases. Biol Reprod. 2001;65(4):1150–1155.
52.
SalesKJJabbourHN. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction. 2003;126(5):559–567.
53.
SalesKJGrantVJabbourHN. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol. 2008;285(1-2):51–61.
54.
KitawakiJ. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):493–502.
55.
FlemingJGSpencerTESafeSHBazerFW. Estrogen regulates transcription of the ovine oxytocin receptor gene through GC-rich SP1 promoter elements. Endocrinology. 2006;147(2):899–911.
56.
TerzidouVLeeYLindstromTJohnsonMThorntonSBennettPR. Regulation of the human oxytocin receptor by nuclear factor-kappaB and CCAAT/enhancer-binding protein-beta. J Clin Endocrinol Metab. 2006;91(6):2317–2326.
57.
WaldNJLawMR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419.
58.
ShenFLiuXGengJGGuoSW. Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for recurrence. Am J Pathol. 2009;175(2):479–488.
59.
ParkerJDLeondiresMSinaiiNPremkumarANiemanLKStrattonP. Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis. Fertil Steril. 2006;86(3):711–715.
60.
KisslerSZangosSKohlJ. Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):204–209.
61.
BerridgeMJIrvineRF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984; 312(5992):315–321.
62.
MatlhagelaKBorsickMRajkhowaTTaubM. Identification of a prostaglandin-responsive element in the Na,K-ATPase beta 1 promoter that is regulated by cAMP and Ca2+. Evidence for an interactive role of cAMP regulatory element-binding protein and Sp1. J Biol Chem. 2005;280(1):334–346.
63.
ZhangXYaoHHuangXLuBXuHZhouC. Nerve fibres in ovarian endometriotic lesions in women with ovarian endometriosis. Hum Reprod. 2010;25(2):392–397.
64.
NieJLiuXSGuoSW. Immunoreactivity of oxytocin receptor (OTR) and transient receptor potential vanilloid type 1 (TRPV1) and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol. 2010;202(4):346.
65.
BullettiCDE ZieglerDSettiPLCicinelliEPolliVFlamigniC. The patterns of uterine contractility in normal menstruating women: from physiology to pathology. Ann N Y Acad Sci. 2004;1034:64–83.
66.
KitlasAOczeretkoESwiateckaJBorowskaMLaudanskiT. Uterine contraction signals–application of the linear synchronization measures. Eur J Obstet Gynecol Reprod Biol. 2009;144(suppl 1):S61–S64.
67.
GreenARStylesJAParrottE. The role of nerve growth factor in the development of adenomyosis in CD-1 mice caused by tamoxifen (Abstract). Toxicol. 2004;194(5):264–265.
68.
ChenMCLinHHsuFNHuangPHLeeGSWangPS. Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells. Am J Physiol Cell Physiol. 2010;299(2):C516–C527.
69.
WalshDAMcWilliamsDFTurleyMJDixonMRFransesREMappPIWilsonD. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford). 2010; 49(10):1852–1861.
70.
ChenJCWileyAAHoTY. Transient estrogen exposure from birth affects uterine expression of developmental markers in neonatal gilts with lasting consequences in pregnant adults. Reproduction. 2010;139(3):623–630.
71.
TarletonBJBradenTDWileyAABartolFF. Estrogen-induced disruption of neonatal porcine uterine development alters adult uterine function. Biol Reprod. 2003;68(4):1387–1393.
72.
TarletonBJWileyAABartolFF. Neonatal estradiol exposure alters uterine morphology and endometrial transcriptional activity in prepubertal gilts. Domest Anim Endocrinol. 2001;21(2):111–125.
73.
HayashiKCarpenterKDSpencerTE. Neonatal estrogen exposure disrupts uterine development in the postnatal sheep. Endocrinology. 2004;145(7):3247–3257.
74.
CimafrancaMADavilaJEkmanGC. Acute and chronic effects of oral genistein administration in neonatal mice. Biol Reprod. 2010;83(1):114–121.
75.
WeaverIC. Epigenetic effects of glucocorticoids. Semin Fetal Neonatal Med. 2009;14(3):143–150.
